Cargando…
SAT-600 Relapse of Agranulocytosis after Recovery of Methimazole-Induced Agranulocytosis
Background: Agranulocytosis is the most feared side effect of antithyroid-drug therapy. In the largest series, agranulocytosis occurred in 0.35 percent receiving methimazole. The causative antithyroid-drug should be stopped and treatment includes broad-spectrum antibiotics and granulocyte-colony sti...
Autores principales: | Choi, Dughyun, Kim, Bo-Yeon, Jung, Chan-Hee, Kim, Chul-Hee, Kang, Sung-Koo, Mok, Ji-Oh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552568/ http://dx.doi.org/10.1210/js.2019-SAT-600 |
Ejemplares similares
-
SAT-625 Dose-Dependent, Methimazole-Induced Agranulocytosis in a Pregnant Hispanic Woman with Grave's Disease
por: Bello, Fatimah, et al.
Publicado: (2019) -
ODP496 Methimazole Induced Agranulocytosis Despite Minimal Intermittent Therapy
por: Uddin, Ashraf, et al.
Publicado: (2022) -
PSAT344 Zeroing In: Methimazole Induced Agranulocytosis in Amiodarone Induced Thyrotoxicosis
por: Gunda, Mouna, et al.
Publicado: (2022) -
FRI505 A Rare Case Of Methimazole Induced Grave Agranulocytosis
por: Barua, Nabonita, et al.
Publicado: (2023) -
SAT478 A Rare Case of Thyrotoxic Periodic Paralysis in a Patient with Concomitant Methimazole-Induced Agranulocytosis
por: Wei, Kevin S, et al.
Publicado: (2023)